Investigating the immune response to COVID-19 Vaccination in Lung Transplantation patients (COVALENT study)
Completed
- Conditions
- lung transplantation100276651004743810024970
- Registration Number
- NL-OMON52266
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Trial is onging in other countries
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 180
Inclusion Criteria
Lung transplant recipients AND patients on witing list for lung trasnplantation
willing to be vaccinated against COVID-19
Exclusion Criteria
History of severe adverse reacton to a vaccine
Waitlist patients with passed COVID-19 infections
active malignancy
Inherited immune deficiency
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method